Compare biologics contract manufacturers for monoclonal antibodies, recombinant proteins, vaccines, and biosimilars. Filter by scale, regulatory status, and therapeutic focus.
Biologics manufacturing spans from early cell line development through commercial-scale production and fill-finish. The process typically involves mammalian cell culture (CHO, HEK293) or microbial fermentation (E. coli, Pichia), followed by multi-step purification and formulation. Each stage requires cGMP-compliant facilities and validated analytical methods.
Scale matters. A CDMO running 2,000L single-use bioreactors serves a different market than one operating 15,000L stainless steel tanks. Buyers should match their clinical stage and projected commercial demand to a manufacturer with the right equipment and experience at that scale.
What certifications should you look for? FDA-registered facilities are required for US-market biologics. EMA compliance matters for European filings. Specific products (biosimilars, vaccines) may require additional regulatory dossiers. Ask about recent inspection history and any Form 483 observations.
No companies found in this category yet. Check back soon.
Browse all CDMOsOur AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.